Clinical Trial Update: Feasibility of Use of BariCare App in Pre-transplant Population [NA]

View source ↗

Summary

A Mayo Clinic trial evaluating the BariCare app feasibility in obesity patients awaiting kidney or liver transplantation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity, Pre-Renal Transplant Candidate | NA | Status: WITHDRAWN